Latest News from JointMedica

The Polymotion® Hip Resurfacing (PHR®) IDE study is closing out 2025 on a high note, having reached 85% enrolment. This milestone represents substantial progress toward study completion and reflects a successful year of steady recruitment across participating sites. As enrolment advances toward its final phase, the study continues to demonstrate strong engagement from both surgeons and patients who are seeking modern, bone-conserving alternatives to total hip replacement. The

Last month marks three years since Dr Jim MacKenzie performed the world’s first Polymotion® Hip Resurfacing (PHR®) procedure in Calgary on 15th November 2022, a milestone in orthopaedic surgery.   The procedure, introduced during an event celebrating Dr MacKenzie’s 20 years of experience in hip resurfacing, showcased the latest metal-on-polyethylene implant design from JointMedica. Designed for active patients seeking bone-conserving alternatives to traditional hip arthroplas

A recent systematic review and meta-analysis evaluated the outcomes of hip resurfacing arthroplasty (HRA) in patients with mild developmental dysplasia of the hip (DDH; Crowe I/II). The review screened 65 articles, with 11 met inclusion criteria, totalling 895 patients and 1,006 hips with DDH, with a mean follow-up of 7.1 years.  Key Findings: ·        Pooled survivorship was 93% and complications occurred in 13% of cases. ·        No statistically significant difference in r

The Polymotion® Hip Resurfacing (PHR®) IDE study has officially passed the 60% enrolment mark , bringing us another step closer to...

A recent study published in International Orthopaedics (2025) reports the longest follow-up to date on the outcomes of hip resurfacing arthroplasty (HRA) in patients under the age of 30. Conducted by Girard et al. at the University of Lille, the research addresses a critical gap in orthopaedic literature, as few long-term data have been available for such a young and active patient population. The retrospective study reviewed the clinical data, and patient recorded outcome me

We’re proud to share that we have successfully completed the 100th surgery in our ongoing U.S. Investigational Device Exemption (IDE)...

Z. Wong et al. conducted a retrospective, propensity score–matched study comparing Hip Resurfacing Arthroplasty (HRA) and Total Hip...

Momentum Builds as Polymotion® Hip Resurfacing IDE Study Reaches 30% Enrolment and Expands to Nine Active Sites. We are pleased to...